Mario Ippolito is a seasoned medical leader with extensive experience in the pharmaceutical industry, currently serving as the External Innovation Medical Lead for BIAL's Global R&D since February 2024. Previously, Mario held the position of Medical Director for the UK, Ireland, and France, where the focus was on building a high-performing team in Neurosciences and Rare Diseases. Mario's career encompasses roles at Ipsen, Celgene, UCB, Servier, Bayer HealthCare, and positions in academic research, contributing to a robust background in Medical Affairs, clinical development, and scientific research. Mario holds a PhD in Pharmaceutical Sciences, a Postgraduate Diploma in Clinical Research, and has been involved in multiple aspects of medical leadership, compliance, and education within the pharma sector.